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Summary 
Decay-accelerating  factor (DAF) is a 70-kD membrane glycoprotein that prevents complement 
(C)-mediated hemolysis by blocking the assembly or accelerating  the decay of C3 convertase. 
Purified DAF is known to incorporate into the membrane of DAF-deficient cells, inhibiting lysis. 
Since Schistosoma mansoni is a blood-dweUing parasite,  we investigated whether DAF can be 
transferred  from human erythrocytes to the worm and protect it against C-mediated killing in 
vitro. We have found that schistosomula (schla) incubated with normal human erythrocytes (N- 
HUE), but not with DAF-deficient erythrocytes, become resistant to C damage in vitro. Protected 
parasites acquire a 70-kD surface protein which can be immunoprecipitated  by anti-DAF antibodies. 
The acquired resistance is abrogated by treatment of N-HuE-incubated parasites with anti-DAF 
antibody. These results indicate that, in vitro, N-HuE DAF can be transferred to schla, and suggest 
its participation in preventing their C-mediated killing. This could represent an important strategy 
of parasites  to evade the host's immune response in vivo. 
I 
n spite of the immune response that Schistosoma mansoni- 
infected hosts develop against the parasite,  adult worms 
can survive for decades in the blood stream, exposed to im- 
mune effectors, without apparent damage (1). One of the 
mechanisms that have been proposed to account for the suc- 
cessful survival of the adult worm is the masking of parasite 
target epitopes by molecules from host origin, acquired during 
worm development (host antigen hypothesis) (2, 3). In vitro 
studies have shown that schistosomula (schla) 1 in contact 
with host erythrocytes (E) acquire cell-derived antigens (4-6) 
and become resistant  to immune attack (7).  However,  de- 
spite the presence of a number of host antigens on the para- 
site surface (4-10) and its correlation with protection against 
1 Abbreviations used in  this paper: DAF, decay-accelerating  factor;  EBSS, 
Earle's balanced salt solution; Elac, EBSS with 0.5% lactalbumin hydrolysate 
and 0.1%  glucose;  fGPS,  fresh  guinea pig serum;  HRF,  homologous 
restriction factor; NHS, normal human serum; NRbS, normal rabbit serum; 
N-HuE, normal human erythrocytes; PIPL, phosphatidylinositol-specific 
phospholipase;  PNH, paroxysmal nocturnal hemoglobinuria; PNH-HuE, 
erythrocytes from PNH patients; schla, schistosomula;  a-schla RbS, anti- 
schistosomula  rabbit serum. 
Part of this work has appeared as a preliminary report: Mere. Inst. Oswaldo 
Cruz Rio J. 82(Suppl.  IV):213.  1987. 
immune damage (7, 10), this hypothesis is weakened by the 
findings that resistant parasite stages can still bind antischisto- 
some antibodies (11-13). In this context, an attractive hy- 
pothesis to explain the role of host antigens in the parasite's 
immune evasion is that the molecules incorporated onto the 
schla surface could provide a specific functional protection 
against immune attack, as we postulated previously (14). Be- 
cause C-mediated killing of schla is considered to be one of 
the mechanisms of immunity in schistosomiasis (15-17) and 
S.  mansoni lives in close contact with blood cells, this role 
could be played by molecules from the E membrane with 
C inhibitory activity. A potential candidate molecule would 
be the decay accelerating  factor  (DAF)  from human E, in 
view of its inhibitory function on the C activation (18-20) 
and its ability to reincorporate into the membranes of DAF- 
deficient cells and render these cells resistant to C-mediated 
lysis (21-22).  In fact,  our earlier  studies provided the first 
suggestive data that DAF from human E can play such a role 
(14). In this paper, we further examined the hypothesis that 
DAF may participate as a functional host antigen by in- 
vestigating: (a)  the ability of normal human erythrocytes 
(N-HuE)  or DAF-deficient  E to protect schla against the 
C-mediated killing in vitro; (b) the presence of human DAF 
on the surface of N-HuE-protected parasites; and (c) the effect 
of anti-DAF antibody in the N-HuE-mediated protection of 
schla in vitro. 
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Parasite.  A Brazilian strain orS. mansoni (L.E., Belo Horizonte, 
Brazil) was used throughout the experiments. Schla were obtained 
by an in vitro mechanical transformation of cercariae, as previously 
described (23). Briefly, cercariae were cooled, centrifuged, and re- 
suspended in Earle's balanced salt solution (EBSS) with 0.5% lac- 
talbumin hydrolysate and 0.1% glucose (Elac),  containing antibi- 
otics and 10 mM Hepes, pH 7.4.  This suspension was vortexed 
for 45 s and the tails were separated form the cercarial  bodies by 
differential  sedimentation at lg in 5 ml Elac for 5 min, three times, 
at room temperature. After a 3-h incubation of the resulting bodies 
in Elac at 37~  larvae are considered to be schla  (24-26). 
Sera.  Anti-schla immune sera were produced in rabbits (a-schla 
RbS) injected intramuscularly with '~30,000  schla  in  1 ml PBS 
emulsified  with  an  equal  volume  of CFA  (Difco  Laboratories, 
Detroit, MI). The rabbits were boosted three times with the same 
number of parasites in IFA at 2-wk intervals. Sera were assayed for 
their ability to induce the C-mediated killing of schla using the 
in vitro cytotoxic assay described below. Normal rabbit sera (NRbS) 
were  obtained  from  the  animals before immunization.  Normal 
human sera (NHS) were obtained from healthy individuals.  Fresh 
guinea-pig serum (fGPS) was used as source of active C. All sera 
were obtained from clotted blood after i h at 4~  and, except those 
used as C, all samples were inactivated at 56~  for 30 min before 
storage at  - 80~  (Bio-Freezer;  Forma Scientific, Marietta, OH). 
FCS  was  purchased  from  Cultilab  (Campinas,  Brazil).  Rabbit 
anti-human DAF serum was kindly donated by Dr. V.  Nussen- 
zweig (New York University Medical School,  New York). 
Preparation of E.  N-HuE, kindly provided by Dr. M~rio S.A. 
Neves (HEMOMINAS blood bank, Belo Horizonte), were obtained 
from healthy donors blood,  regardless  of the ABO group,  with 
negative tests for hepatitis B, syphilis,  Chagas' disease and AIDS. 
PNH-HuE, with positive Ham's test (27), were obtained from seven 
individual samples of blood, kindly provided by Dr. Romeu I. Car- 
valho (Hospital Fellcio  Rocho, Belo Horizonte). SRBC were ob- 
tained from animals maintained at the Veterinary School, Univer- 
sidade Federal de Minas Gerais, Belo Horizonte. Blood was conserved 
for 1-4 wk in equal volume of Alsever's solution at 4~  and were 
washed in Elac when required. Treatment of N-HuE with trypsin 
and pronase were carried out as described elsewhere (28, 29). Briefly, 
N-HuE free of plasma proteins were incubated with pronase (1 
mg/ml) or with trypsin (150/zg/ml) in 0.02 M phosphate buffer 
containing 0.2 M  NaC1 for 1 h at 37~  and then washed to re- 
move enzymes. 
Preparation of E Ghosts and Membrane Protein Fraction.  N-HuE 
ghosts and E membrane proteins were prepared as described by 
Nicholson-Weller et al.  (20).  Briefly,  E were extensively washed 
with PBS and then lysed with 5 mM phosphate buffer, pH 7.5, 
containing 1 mM EDTA at 4~  The resulting E ghosts were washed 
out of hemoglobin by centrifugation (10,000g,  30 rain), resuspended 
in the same buffer, and stored at  -80~  until required. Alterna- 
tively,  N-butanol was added to this membrane preparation, with 
stirring, at 4~  to a final concentration of 20% (vol/vol), and stir- 
ring was continued for 30 min. This process was repeated, as de- 
scribed (20), and the butanol-saturated aqueous phase was dialyzed 
extensively against Earle's  solution before incubation with schla. 
Protein was quantified by the method of Lowry (30). 
Assay of Susceptibility of Schla to C-mediated Killing.  A modified 
in vitro assay originally described by Clegg and Smithers (7) was 
used.  Our assay consisted of a 24-h incubation of 3-h schla with 
E or fractions,  to allow the acquisition  of host antigens by the para- 
sites, followed by a C-mediated cytotoxic assay, to evaluate the de- 
gree of protection afforded to the parasites during the previous step. 
Alternatively,  schla incubated with N-HuE were treated with anti- 
DAF mAb before the cytotoxic assay, as described below. 
Incubation of  Schla with E or Fmctions.  Approximately 2,000 schla 
were incubated with  1% packed N-HuE (or equivalent amount 
of E ghosts or 250 #g/ml membrane protein fraction), PNH-HuE 
or SRBC  in  2 ml Iscove's modified Dulbecco's medium (Sigma 
Chemical Co., St. Louis, MO), either in the absence or in the pres- 
ence of 5% FCS or NHS in 24-well plastic culture plates (Tissue 
Culture Cluster; Costar, Cambridge, MA). After 24 h, parasites 
were extensively washed by differential sedimentation  at  1 g,  at 
room temperature, until free host material was completely removed. 
Treatment of Schla with anti-DAF Antibody.  After 24 h of incu- 
bation with N-HuE in the presence of FCS, washed parasites were 
incubated for 30 min with  10 #1 of the IA10 anti-human DAF 
IgG2a mAb (31) (8.5 mg/ml) (gift of Dr. V. Nussenzweig, New 
York University Medical School).  The parasites  were washed to 
remove unbound antibodies and then assayed for their susceptibility 
to C-mediated cytotoxicity. 
Cytotoxic Assay.  250 schla were incubated in 250/A Elac for 
30 rain in 96-well microplates (Microtest II, Tissue Culture Plate; 
Falcon  Plastics,  Oxnard,  CA) with or without  100/zl of a-schla 
RbS (final dilution 1:64), washed, and incubated with fGPS (final 
dilution 1:25), as source of C. After 18-24 h, schla were examined 
at 40x  with an inverted microscope (Olympus; model, IMT, Japan) 
and the percentage of dead or damaged schla was determined. These 
parasites  were easily recognized by their immobility and opaque 
granular appearance.  Incubations were carried out in 5%  CO2/ 
95%  air at 37~  (Water Jacketed CO2 incubator,  model 3157; 
Forma Scientific,  Marietta, OH) and the whole experiment was 
carried out under  sterile  conditions. 
All experiments throughout this work were repeated two to five 
times and each  figure represents  a typical result. 
Schla Surface Immunoenzymatic Assay.  Approximately 1,000 live 
schla, previously incubated for 24 h either in the absence or in the 
presence of N-HuE, were treated with  100/A of a-schla  RbS or 
NRbS in 96-well flat-bottomed ELISA plates pre-coated with 1% 
casein in PBS. Excess proteins were washed out and parasites were 
incubated with an affinity purified goat anti-rabbit IgG (H+L) 
horseradish peroxidase conjugate (Bio-Rad Laboratories, Richmond, 
CA). Each incubation was carried out at room temperature for 40 
rain and parasites were washed with EBSS containing 0.5% NRbS, 
to minimize nonspecific  binding of conjugate to schla.  After last 
washing (EBSS without serum), parasites were incubated with 100 
#1 of a solution of 0.02%  (wt/vol) orthophenylenodiamine and 
0.02%  (vol/vol) H202 in a phosphate-citrate buffer pH 5.0 (0.1 M 
Na2HPO4, 0.05 M  citric acid).  After 15 rain of enzymatic reac- 
tion, supematants were removed and added to clean wells containing 
20 #1 of 20%  H2SO4 to be read at 492  nm in an ELISA reader 
(Uniskan;  Eflab,  Eflab  Oy, Helsinki,  Finland). 
Immunoprecipitation.  About 300,000 3-h or 24-h schla were in- 
cubated with N-HuE ghosts, in the absence of serum, and washed 
extensively until all E membrane traces were removed. The para- 
sites were then surface iodinated with 500/~Ci 125I by the method 
of Iodogen (Pierce  Chemical Co.,  Rockford,  IL). Labeled  mole- 
cules were extracted with 1% NP-40 in 50 mM Tris and 150 mM 
NaC1, containing the following protease inhibitors:  PMSF (10 mM), 
EDTA (10 raM), iodoacetamide (10 raM),  antipain (0.1 mg/ml), 
and leupeptin (0.1  mg/ml). Aliquots of the extracts, containing 
3  x  106 cpm, were treated with staphylococcal protein A-Sepha- 
rose beads previously incubated with either the monoclonal mouse 
anti-human DAF IgG2a (IA10) (31) or a rabbit anti-human DAF 
serum (32). The protein A-Sepharose antibody-antigen complexes 
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conditions (33, 34) followed by autoradiography of dried gels. 
Results 
Effect of N-HuE in the Susceptibility of Schla to the C-mediated 
Killing.  Two representative experiments show the suscepti- 
bility of schla to C-mediated killing in vitro before and after 
incubation with N-HuE (Fig.  1). In experiment 1 it is ob- 
served that, whereas 85% of recently transformed larvae (3-h 
schla) (a) and 80% of the parasites incubated in chemically 
defined medium (24-h schla) (b) are killed by C when coated 
with anti-schla antibodies, only 30% of the schla previously 
cultured in the presence of N-HuE (24-h N-HuE schla) (c) 
are susceptible to immune damage. These results show that 
N-HuE have the ability to confer resistance to schla against 
the antibody-dependent C-mediated killing in vitro.  The 
N-HuE-mediated protection is even greater when 24-h N-HuE 
schla are incubated in the presence of FCS (d) or NHS (not 
shown). In these cases, almost 100% of the parasites become 
resistant to the lethal effect of antibody and C. The protec- 
tive effect of N-HuE is also observed when schla is exposed 
only to the alternative pathway of C activation. This is par- 
ticularly evident when mortality of 24-h schla exposed to 
C alone (b) happens to be high, as occurs in the analogous 
experiment 2. This finding indicates that N-HuE-mediated 
mechanism of schla protection acts at the level of C activation. 
Binding of lgG Anti-schla to the Surface fiN-HuE-protected 
Parasites.  To verify whether the resistance of schla to anti- 
body and C-mediated killing is due to the masking of target 
epitopes by N-HuE-derived molecules, we investigated the 
ability of anti-schla antibody to bind to the surface of N-HuE- 
protected parasites.  The antibody binding was determined 
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Figure 2.  Binding  of IgG anti-schh to the surface of N-HuE-protected 
parasites. 3-h schla (a) or schla previously cultured for 24 h in medium 
chemically defined (b) or supplemented with N-HuE (c) or N-HuE  + 
FCS (d) were incubated with a-schla RbS or NRbS and then with goat 
anti-rabbit IgG. Each point represents the mean OD from duplicate su- 
pernatant samples after the addition of substrate to Ab-coated schla. Para- 
sites were taken from the same preparation used in the experiment repre- 
sented in Exp.  1, Fig.  1. 
by an immunoenzymatic reaction on the surface of schla as 
described in Materials and Methods. Fig. 2 shows that pro- 
tected parasites previously incubated with N-HuE either in 
the absence (c) or in the presence  of FCS (d) are still able 
to bind anti-schla IgG, as compared to the controls with NRbS 
and parasites which did not have any contact with N-HuE 
(a and b). These results,  confirmed by immunofluorescence 
(data not shown), suggest that the resistance conferred by 
N-HuE to schla is not due to a failure of anti-schla antibodies 
Ab  4.  Ci  [--~  C  ~  Ab  +  C 
100 
80 
0 
o~ 
o  60 
~  40 
a 
20 
(a)  (b)  (c)  (d)  (a)  (b)  (c)  (d) 
INCt..SATION  24  H 
Effect of N-HuE in the susceptibility of schla to C-mediated  Figure 1. 
killing. Values shown in analogous Exps.  1 and 2 are the mean percent 
of parasite killing mediated by C, Ab +  C or Ab  +  Ci from duplicate 
samples of 3-h schla (a) or schla previously cultured for 24 h in medium 
chemically defined (b) or supplemented with N-HuE (c) or N-HuE  + 
FCS (d). All experiments throughout this work were repeated two to five 
times with similar results. 
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Figure 3.  Effect  of N-HuE ghosts, hemoglobin or membrane proteins 
in the susceptibility of schla to C-mediated killing. Values shown are the 
mean percent of parasite killing mediated by C or Ab + C from duplicate 
samples of schla previously cultured for 24 h in medium supplemented 
with FCS (a), FCS  +  N-HuE (b), FCS  +  N-HuE ghosts  (c), FCS  + 
N-HuE hemoglobin-rich  fraction (d), or FCS +  N-HuE membrane pro- 
teins (e). Background mortality in the presence of Ab +  Ci (<17%) was 
subtracted from morality mediated by C  or Ab  +  C. 
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the previous suggestion that the protective effect seems to 
be due to an inhibition of C activation on the parasite surface. 
The Protection of  Schla Is Mediated by N-HuE Membrane Pro- 
reins.  To identify the cellular component involved in the schla 
protection, E were lysed, and schla were incubated with ei- 
ther the membrane- or the hemoglobin-rich fraction, in the 
presence of FCS, to maximize the degree of schla protection. 
As seen in Fig. 3, while the membrane fraction (c) is able 
to protect the larvae from immune damage, the mortality 
of schla incubated with the hemoglobin-rich fraction (aT) is 
equivalent to that observed for the larvae incubated in cell- 
flee FCS-containing medium (a). Schla incubated with the 
delipidated protein fraction of N-HuE membrane (e) become 
totally  resistant  to  the  antibody-dependent  C-mediated 
damage. These results show that the protection of schla is 
mediated by N-HuE membrane proteins. 
Effect of Trypsin- and Pronase-treated N-HuE in the Suscepti- 
bility of Schla to the C-mediated Killing.  DAF and the CR1 
C3b receptor are two N-NuE membrane proteins that down 
regulate C activation (20, 35). Trypsin is known to remove 
CR1 and glycophorin from N-HuE surface, without affecting 
DAF activity (28, 29, 36). On the other hand, the treatment 
of N-HuE with pronase abolishes the DAF activity rendering 
the cells C-sensitive (29). To investigate whether trypsin or 
pronase treatment affects the ability of N-HuE to protect the 
parasite, intact cells were treated with these enzymes and then 
incubated with schla in the presence of FCS (Fig.  4). 
Trypsin-treated N-HuE fully retain their ability to confer 
protection to parasites against C-mediated damage in vitro 
(Exp.  1): ghosts from trypsinized (b) as well as from non- 
trypsinized N-HuE (a) confer equivalent levels of protection 
to schla, in relation to larvae incubated with FCS alone. This 
does not occur when pronase is used (Exp. 2). On the con- 
trary, treatment of N-HuE with pronase (b) completely abol- 
ishes the protective effect of N-HuE  (a). 
Pronase- but not trypsin-treated N-HuE protein fractions 
lost the 70-kD band recognized by anti-DAF antibodies by 
immunoblotting after  SDS-PAGE,  showing  the  efficient 
removal of DAF by pronase.  The efficiency of trypsin was 
verified by the fact that E treated with the enzyme was to- 
tally depleted of glycophorin, the major E surface protein, 
as indicated by the periodic acid Schiff staining after SDS- 
PAGE (data not shown). 
These results rule out the participation of glycophorin and 
probably of CR1 in the N-HuE-mediated protection of schla 
and indicate the possible  involvement of DAE 
Effect  of DAtZdeficient  E  in  the Susceptibilit2/ of Schla  to 
C-mediatedKilling.  PNH-HuE (29, 37) and SRBC (21), both 
extremely sensitive to C-mediated lysis, are known to be nat- 
urally deficient in DAF. We, therefore, investigated whether 
these DAF-deficient  cells are able to protect schla from the 
C-mediated killing. In Fig. 5, we can observe that the mor- 
tality of schla incubated with either PNH-HuE (c and aT) or 
SRBC (e) in the presence of FCS is equivalent to that ob- 
served for the larvae incubated in cell-flee FCS-containing 
medium (a), demonstrating that neither cell type is able to 
protect schla as N-HuE (b). All PNH-HuE donors were in 
the crisis period of the disease at the time of blood collec- 
tion. DAF deficiency was confirmed by a dot blot screening 
of the PNH-HuE membrane proteins which did not react 
with anti-DAF antibodies as opposed to N-HuE (not shown). 
So far, our results demonstrate that resistance of schla upon 
contact with  N-HuE  is  conferred by a pronase-sensitive, 
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Figure 4.  Effect  of trypsin- and pronase-treated N-HuE in the suscepti- 
bility of schla to C-mediated killing. N-HuE were treated with trypsin 
(Exp. 1) or pronase (Exp. 2) before incubation  with parasites. Data repre- 
sent the mean percent protection against killing mediated by Ab  +  C 
of duplicate samples of schla were previously cultured for 24 h in medium 
supplemented with FCS + N-HuE (a) and FCS + enzyme-treated N-HuE 
(b) in relation to parasites incubated with FCS alone. Background mor- 
tality in the presence of Ab +  Ci (<14%) was subtracted from mortality 
mediated by Ab  +  C, before calculations were done. 
40 
3O 
20 
I-~  C 
~Ab+C 
(o)  (b)  (c)  (d)  (,) 
INCUBATION 24  H 
Figure 5.  Effect  of DAF-deficient E in the susceptibility of schla to 
C-mediated killing. Each point represents the mean percent of parasite 
killing mediated by C or Ab +  C from duplicate samples of schla previ- 
ously cultured for 24 h in medium supplemented with FCS (a), FCS  + 
N-HuE (b), FCS +  PNH-HuE (c, patient 1, d, patient 2, representative 
of seven  that presented identical results), and SRBC (e). Background mor- 
tality in the presence of Ab +  Ci (<10%) was subtracted from mortality 
mediated by C  or Ab  +  C. 
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of N-HuE and absent from SRBC and PNH-HuE. Thus this 
inhibition could conceivably  be due to DAF. 
Presence of  DAF on the Su~ace fiN.HuE-incubated Schla.  To 
investigate for the presence  of human DAF on the surface 
of schla, parasites protected by N-HuE ghosts in the absence 
of serum as well as 3-h schla were surface labelled with t2sI, 
and NP40-soluble proteins were immunoprecipitated with 
anti-human DAF antibodies, known to react with the 70-kD 
form of human E (31, 32).  As shown in Fig.  6, both the 
monoclonal (mouse IgG2a)  (a)  and the polyclonal (rabbit 
serum) (b) anti-human DAF antibodies are able to immuno- 
precipitate from extracts  of protected schla a surface protein 
of Mr 70 kD (lane 2), absent from 3-h susceptible parasites 
(lane 1). Other bands are visible in immunoprecipitates from 
24-h N-HuE schla but not 3-h schla, namely 110, 140, and 
>200 kD (b), a doublet between 66 and 45 kD, two bands 
between 45 and 29 kD, and four other bands below 29 kD 
(a and b). The low molecular mass band seen in the control 
of the polyclonal antibody (b) seems to be due to nonspecific 
binding, as usually occurs when total serum is used. The pres- 
ence of anti-DAF-reactive  proteins in 24-h N-HuE schla and 
their absence in 3-h worms clearly demonstrate that schla 
can acquire DAF from the human red cells. 
Effect of  Anti-DAF Antibody in the Acquired Resistance of  Schla 
to the C-mediated  Killing.  24-h  N-HuE  schla incubated in 
the presence of FCS and washed were treated with anti-DAF 
mAb before the cytotoxic assay, and the results are presented 
in Fig. 7. Parasites treated with the mAb (c) become as sus- 
ceptible to C-mediated killing as those incubated with FCS 
only (a) or with PNH-HUE plus FCS (d). This clearly shows 
that the anti-DAF antibody completely abrogates  the pro- 
tection afforded by N-HuE, indicating that the human DAF 
molecules present on the surface of schla are involved in the 
protection of the parasite against the C-mediated killing in 
vitro. 
Discussion 
DAF is a 70-kD glycosilphoshatidylinositol-anchored mem- 
brane glycoprotein that prevents the assembly and disassociates 
the membrane-bound (20,  21) and fluid phase (38) classical 
and alternative pathway C3 convertases. In the present study, 
we described for the first time that DAF from human E can 
be transferred to the S. raansoni schla surface, and we present 
evidence that strongly suggest that it plays a substantial role 
in the parasite  evasion from C-mediated killing in vitro. 
Our initial observation that schla incubated with N-HuE 
become more resistant  to antibody plus C-mediated killing 
in vitro  (Fig.  1)  has  already  been reported by Clegg and 
Smithers (7) using rhesus monkey E in the presence of ho- 
mologous serum. This protection was attributed to the failure 
of antibody binding due to the masking of target epitopes 
by host molecules (2-6).  However,  like others (10-13),  we 
have shown that anti-schla  IgG can still bind to the surface 
of N-HuE-protected schla (Fig. 2 and our unpublished in- 
direct immunofluorescence  results).  The suggestion that the 
protective effect occurs mainly at the level of C  activation, 
rather than antibody binding, is supported by our observa- 
tion that N-HuE treatment also inhibits the parasite killing 
due to the activation of the alternative pathway of C, (more 
evident in Fig. 1, exp. 2 [c and d]), but also in Fig. 5 [b] and 
Fig.  7 [b]). 
Figure 6.  Detection of anti-DAF reactive molecules on the surface of 
N-HuE-protected schla. Susceptible 3-h schla (lane I) or schla protected 
from C-mediated killing  after incubation  for 24 h in culture medium con- 
taining N-HuE ghosts (lane 2) were extensively washed and parasites sur- 
face was radioiodinated.  Extracts were immunoprecipirated  with mono- 
clonal murine IgG2a (a) or polyclonal rabbit serum (b) anti-human DAF 
followed by resolution  of proteins by SDS-PAGE on a 5-13% gradient 
gel. Size of standards are shown to the left in kiloDahons. 
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Figure 7.  Effect of anti-DAF antibody in the susceptibility of schh to 
C-mediated  killing.  Data represent the mean percent of parasite killing 
mediated by C or Ab  +  C  from duplicate samples of schla previously 
cultured for 24 h in medium supplemented with FCS (a), FCS +  N-HuE 
(b), FCS  +  N-NuE, anti-DAF--treated (c), or FCS  +  PNH-HuE (d, pa- 
tient 3). Background mortality in the presence of Ab +  Ci (<20%) was 
subtracted  from  mortality mediated by C  or Ab  +  C. The protective activity we describe here resides in the pro- 
tein fraction of N-HuE membrane (Fig. 3). The nature of 
this molecule was further investigated by taking advantage 
of two proteolytic enzymes, known to have different behaviors 
towards DAF. Pronase can remove DAF from the N-HuE 
surface, causing the cells to become susceptible  to lysis by 
C (29). Trypsin does not affect either the integrity of DAF 
or the resistance of cells to C (29, 36), but removes the CR1 
C3b receptor (29), another H-like protein, and glycophorin 
(28, 36). The observation that pronase, but not trypsin, abol- 
ishes the protective effect of N-HuE  (Fig. 4) is consistent 
with the notion that this protection is DAF-mediated. More- 
over, the fact that trypsin-treated N-HuE, depleted of gly- 
cophorin, fully retain the ability to confer protection to schla 
against C-mediated damage in vitro rules out the participa- 
tion of glycophorin and suggests that CR1 is not involved 
in this protection. 
The first approach to validate our hypothesis that N-HuE 
DAF is involved in the protection phenomenon was based 
on the argument that if DAF were responsible for schla es- 
cape from immune attack, then DAF-deficient  cells would 
be unable to protect parasites from C-mediated killing in vitro. 
In fact, this was the case. The finding that PNH-HuE and 
SRBC, which lack DAF (21, 29, 37), have no ability to pro- 
tect the parasite from C  damage in vitro (Fig. 5) strongly 
indicates that this molecule may be involved in the protec- 
tion conferred by N-HuE to schla. 
As also reported by others (4-6), previous results from this 
laboratory,  using anti-N-HuE antibody in the immunoen- 
zymatic assay described here, have indicated the presence of 
N-HuE molecules on the surface of protected schla that had 
been incubated for 24 h with N-HuE (our unpublished results). 
Here, we demonstrate that DAF is among the N-HuE mole- 
cules transferred to the parasites by showing in their surface 
a 70-kD protein recognized by both monoclonal and poly- 
clonal anti-human DAF antibodies (Fig. 6). Preliminary un- 
published results have shown that the presence of puromycin 
during the incubation of schla with N-HuE does not pre- 
vent the acquisition of resistance by the parasites. The nonre- 
quirement of protein synthesis in this process suggests that 
DAF is from host origin. 
Recently, additional forms of DAF with Mr other than 
70 kD have been identified. Kinoshita et al. (39) described 
a HuE membrane molecule of 140 kD, also absent from PNH- 
HuE, reactive with mAbs anti-human DAF and able to ac- 
celerate the decay of C3 convertase of the classical pathway. 
Seya et al. (40) identified 55-kD monomeric forms of DAF 
and 450-kD aggregates of 63-kD subunits. In our experi- 
ment, the bands of Mr 110, 140, and >200 kD, reactive with 
the polyclonal anti-DAF (Fig.  6 a) as well as those of Mr 
<70 kD found in 24-h N-HuE schla (Fig. 6, a and b), may 
represent these other forms of DAF. Another possible expla- 
nation for the bands of Mr <70 kD is the possible  occur- 
rence of proteolytic degradation of DAF during the manipu- 
lation process,  since they are not seen i,. 3-h schla. 
The functional aspect of the protective effect was approached 
based on the assumption that ifDAF were transferred to schla 
surface, anti-DAF antibodies would impair the protection of 
the parasites by blocking its activity.  Our results that anti- 
DAF mAb completely prevented the acquisition of protec- 
tion by the parasite (Fig.  7) corroborated this assumption. 
It is unlikely that the lack of protection is due to an increase 
in C3b deposition caused by anti-DAF antibodies since we 
already  had  an  excess of a-schla  antibody  and  since  no 
significant  increase in the killing mediated by C alone was 
observed. Therefore, we have functional evidence that human 
DAF molecules in the surface of schla may play a role in the 
evasion of the parasite in vitro. 
Other molecules, such as the homologous restriction factor 
(HRF), present in N-HuE but absent  in PNH-HuE (41), 
are known to interfere with C activity (42). The participa- 
tion of HRF in the phenomenon described here is unlikely, 
since the protective effect is completely blocked by mAbs 
specific to DAF and since the inhibitory effect was upon het- 
erologous C. It has been shown that DAF does not function 
in a species restricted manner, at least for the heterologous 
system involving human DAF-guinea-pig C (18, 19), rabbit 
DAF-guinea-pig C  (43) and human DAF-rabbit C  (44). 
The above results led us to conclude that, in vitro, DAF 
from N-HuE can be transferred to the schla surface and par- 
ticipate in the protection of the parasite against C-mediated 
killing either in the presence or absence of anti-schla  anti- 
bodies. Other investigators have also suggested the involve- 
ment of this molecule in the evasion of the parasite of the 
alternative C pathway, providing preliminary evidence for the 
detection of host DAF on the membrane of 14-d-old schla 
recovered from guinea pig (45). 
We are currently investigating the mechanisms whereby 
DAF is transferred  to the surface of schla. Preliminary un- 
published data lead us to presume that DAF sheds from the 
N-HuE membrane, as shown in human polymorphonuclear 
cells (46), goes into solution and then binds to the surface 
of the parasite, possibly to a specific  protein acceptor molecule. 
Certainly,  other mechanisms account for S.  mansoni eva- 
sion from the host immune system and it is probable that 
they act in conjunction. Our findings that, in vitro, N-HuE- 
mediated resistance of schla is improved in the presence of 
serum support this view. It is possible that soluble DAF present 
in serum (47) also binds to the parasite surface contributing 
to an increase in the parasite resistance. It is also possible that 
serum phosphatidylinositol-specific phospholipases (PIPL), 
e.g., PIPLD (48, 49), amplify the release of membrane N-HuE 
DAF,  thus enhancing its uptake by the parasite. 
The acquisition of a particular E molecule with C regula- 
tory function, such as DAF, could explain, for instance, why 
anti-E antibodies can damage adult parasites bearing E an- 
tigens in vivo (2, 4), whereas anti-alloantigens do not affect 
the survival in the host of worms bearing MHC determinants 
(50). Although several questions still need to be answered, 
our findings may explain the paradox of the ability ofS. man- 
soni to escape immune damage by the acquisition of host an- 
tigens despite the presence of specific antibodies on their sur- 
face. DAF,  as an acquired  functional host antigen, might 
represent an important mechanism used by schistosomes, as 
well as by other parasites, to evade immune killing mediated 
by antibody and C  in vivo. 
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